Business
Tenaya Therapeutics to Participate in Upcoming Investor and Industry Conferences
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and
About this update from Tenaya Therapeutics, Inc.
[{"type":"text","content":" SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--\nTenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced today that Faraz Ali, Chief Executive Officer, is scheduled to participate in the Chardan 5th Annual Genetic Medicines Conference, the Alliance for Regenerative Medicine’s Cell and Gene Meeting on the Mesa and the Jefferies Gene Therapy/Editing Summit in October. Details of the presentations are as follows:\n\nChardan 5th Annual Genetic Medicines Conference\nPanel: Genetic Medicines: The Ongoing Emergence of the Heart as a Target Tissue\nDate: Monday, October 4, 2021\nTime: 3:00 p.m. ET\n\nFireside Chat\nDate: Monday, October 4, 2021\nTime: 4:00 p.m. ET\n\nAlliance for Regenerative Medicine’s Cell and Gene Meeting on the Mesa\nPanel: Personalizing Cardiovascular Therapies To Address The Underlying Causes Of Disease\nDate: Wednesday, October 13, 2021\nTime: 3:15 p.m. PT\n\nCompany Presentation\nDate: Wednesday, October 13, 2021\nTime: 4:45 p.m. PT\n\nJefferies Gene Therapy/Editing Summit\nCompany Presentation\nDate: Thursday, October 28, 2021\nTime: 11:30 a.m ET\n\nAbout Tenaya Therapeutics\n\nTenaya Therapeutics is a biotechnology company committed to a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of heart disease. Founded by leading cardiovascular scientists from Gladstone Institutes and the University of Texas Southwestern Medical Center, Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. For more information, visit www.tenayatherapeutics.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210930006008/en/\n\nFor more information:\nInvestor Contact\nLeone Patterson\nTenaya Therapeutics\[email protected]\n\nMedia Contact:\nWendy Ryan\nTen Bridge Communications\[email protected]\n\nSource: Tenaya Therapeutics","length":5000,"tagName":"div"}]